HOLLENCREST CAPITAL MANAGEMENT - SEELOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
HOLLENCREST CAPITAL MANAGEMENT ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$478
-84.6%
2,6000.0%0.00%
Q2 2023$3,107
+72.9%
2,6000.0%0.00%
Q1 2023$1,797
+1.8%
2,6000.0%0.00%
Q4 2022$1,765
-96.7%
2,600
-88.5%
0.00%
-100.0%
Q3 2021$54,000
-14.3%
22,600
-4.2%
0.01%
-16.7%
Q2 2021$63,000
-45.2%
23,600
+2.6%
0.01%
-45.5%
Q1 2021$115,00023,0000.01%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders